CA2001502A1 - Cyclosporin ophthalmic compositions - Google Patents

Cyclosporin ophthalmic compositions

Info

Publication number
CA2001502A1
CA2001502A1 CA002001502A CA2001502A CA2001502A1 CA 2001502 A1 CA2001502 A1 CA 2001502A1 CA 002001502 A CA002001502 A CA 002001502A CA 2001502 A CA2001502 A CA 2001502A CA 2001502 A1 CA2001502 A1 CA 2001502A1
Authority
CA
Canada
Prior art keywords
eye
composition
composition according
compositions
ciclosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002001502A
Other languages
English (en)
French (fr)
Inventor
Ronald E. Peeples
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2001502A1 publication Critical patent/CA2001502A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA002001502A 1988-10-26 1989-10-25 Cyclosporin ophthalmic compositions Abandoned CA2001502A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26
US262,866 1988-10-26

Publications (1)

Publication Number Publication Date
CA2001502A1 true CA2001502A1 (en) 1990-04-26

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002001502A Abandoned CA2001502A1 (en) 1988-10-26 1989-10-25 Cyclosporin ophthalmic compositions

Country Status (24)

Country Link
JP (1) JPH02164830A ( )
KR (1) KR900005973A ( )
AU (1) AU626928B2 ( )
BE (1) BE1003578A4 ( )
CA (1) CA2001502A1 ( )
CH (1) CH679210A5 ( )
DE (1) DE3935517A1 ( )
DK (1) DK531289A ( )
ES (1) ES2020032A6 ( )
FI (1) FI895064A0 ( )
FR (1) FR2638089A1 ( )
GB (1) GB2224205B ( )
GR (1) GR1000611B ( )
HU (1) HU203046B ( )
IL (1) IL92120A ( )
IT (1) IT1237824B ( )
LU (1) LU87613A1 ( )
MY (1) MY106271A ( )
NL (1) NL8902657A ( )
NO (1) NO894266L ( )
NZ (1) NZ231131A ( )
PT (1) PT92120B ( )
SE (1) SE8903583L ( )
ZA (1) ZA898140B ( )

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
ES2098739T3 (es) * 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
ES2402321T3 (es) * 2007-11-05 2013-04-30 Bausch & Lomb Incorporated Materiales inmiscibles en agua como vehículos para el suministro de fármacos
WO2010141648A2 (en) * 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
EP3223794A1 (en) 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
IL92120A0 (en) 1990-07-12
CH679210A5 ( ) 1992-01-15
AU4371589A (en) 1990-05-03
GB2224205A (en) 1990-05-02
NZ231131A (en) 1992-06-25
DK531289D0 (da) 1989-10-25
KR900005973A (ko) 1990-05-07
NO894266L (no) 1990-04-27
FI895064A0 (fi) 1989-10-25
NL8902657A (nl) 1990-05-16
HU895444D0 (en) 1990-01-28
IL92120A (en) 1994-02-27
BE1003578A4 (fr) 1992-04-28
MY106271A (en) 1995-04-29
IT1237824B (it) 1993-06-18
GB8924040D0 (en) 1989-12-13
DE3935517A1 (de) 1990-05-03
PT92120A (pt) 1990-04-30
NO894266D0 (no) 1989-10-26
GR1000611B (el) 1992-08-31
HUT52394A (en) 1990-07-28
SE8903583D0 (sv) 1989-10-26
DK531289A (da) 1990-04-27
GR890100690A (en) 1990-11-29
JPH02164830A (ja) 1990-06-25
IT8948485A0 (it) 1989-10-26
AU626928B2 (en) 1992-08-13
GB2224205B (en) 1992-04-15
FR2638089A1 (fr) 1990-04-27
PT92120B (pt) 1995-06-30
SE8903583L (sv) 1990-04-27
HU203046B (en) 1991-05-28
ES2020032A6 (es) 1991-07-16
LU87613A1 (fr) 1991-05-07
ZA898140B (en) 1991-06-26

Similar Documents

Publication Publication Date Title
AU626928B2 (en) Cyclosporin opthalmic compositions
US5951971A (en) Ophthalmic compositions
Constad et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
EP0089815B1 (en) Liquid perfluorocarbons, for use in ocular therapy, and preparations containing them
Flach et al. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier
JPH0216728B2 ( )
CN112135603B (zh) 包含奈必洛尔的药物组合物
CZ423797A3 (cs) Topické přípravky s imunosupresivy
US5308624A (en) Ophthalmic product
Miki et al. Intraocular cannula for continuous, chronic drug delivery: histopathologic observations and function
JP2967523B2 (ja) 眼病用製薬組成物
DE69200365T2 (de) Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
CN108338980A (zh) 绿原酸在制备防治眼部炎症的药物中的用途
JPH08508975A (ja) 眼科薬送達ビヒクルとしてのサブミクロン乳剤
WO2001028553A1 (en) Rivastigmine for the treatment of ocular disorders
Grehn et al. Thymoxamine: a miotic for intraocular use
Jay et al. Further studies on the effect of retrobulbar epinephrine injection on ocular and optic nerve blood flow
US5279836A (en) Topical use of calcitonin for the preparation of medications in senile idiopathic cataract and a pharmaeutical composition thereof
Alani et al. The ophthalmic rod—a new drug-delivery system II
RU2051651C1 (ru) Основа для глазных капель
Yamaguchi et al. Corticosteroid therapy after anterior radial keratotomy in primates
ZALTA et al. The effect of nitroglycerin ointment on the external ocular structures of rabbits
Kralinger et al. Acetyl-Salicylsäure–Silikonöl-Suspension bei proliferativer Vitreoretinopathie: Erste Ergebnisse der österreichischen Multicenter-Studie

Legal Events

Date Code Title Description
FZDE Discontinued